# Douglas Emmett Inc: financial statements, quarterly

DEI · NYSE · CIK 1364250 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dei.md) · [Financials](/companies/dei/financials.md) · [Filings](/companies/dei/filings.md) · [Insiders](/companies/dei/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dei/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [23.4](/filings/0001364250-23-000070.md) | [951 d](/filings/0001364250-26-000011.md) | [245](/filings/0001364250-25-000028.md) | [246](/filings/0001364250-25-000036.md) | [251](/filings/0001364250-25-000044.md) | [245 d](/filings/0001364250-26-000011.md) | [252](/filings/0001364250-26-000032.md) | [252](/filings/0001364250-26-000041.md) | [251](/filings/0001364250-25-000044.md) | [249 d](/filings/0001364250-26-000011.md) | [251](/filings/0001364250-26-000032.md) | [257](/filings/0001364250-26-000041.md) |
| Gross profit | $m | [164](/filings/0001364250-24-000048.md) | [168 d](/filings/0001364250-26-000011.md) | [162](/filings/0001364250-25-000028.md) | [163](/filings/0001364250-25-000036.md) | [156](/filings/0001364250-25-000044.md) | [156 d](/filings/0001364250-26-000011.md) | [162](/filings/0001364250-26-000032.md) | [160](/filings/0001364250-26-000041.md) | [159](/filings/0001364250-25-000044.md) | [155 d](/filings/0001364250-26-000011.md) | [160](/filings/0001364250-26-000032.md) | [162](/filings/0001364250-26-000041.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [56.0](/filings/0001364250-23-000070.md) | [57.6 d](/filings/0001364250-24-000012.md) | [55.3](/filings/0001364250-24-000028.md) | [55.0](/filings/0001364250-25-000036.md) | [56.8](/filings/0001364250-25-000044.md) | [62.3 d](/filings/0001364250-26-000011.md) | [60.1](/filings/0001364250-26-000032.md) | [65.3](/filings/0001364250-26-000041.md) | [72.8](/filings/0001364250-25-000044.md) | [68.5 d](/filings/0001364250-26-000011.md) | [64.5](/filings/0001364250-26-000032.md) | [68.3](/filings/0001364250-26-000041.md) |
| Net income | $m | [(13.4)](/filings/0001364250-24-000048.md) | [(40.5) d](/filings/0001364250-26-000011.md) | [8.9](/filings/0001364250-25-000028.md) | [10.9](/filings/0001364250-25-000036.md) | [4.6](/filings/0001364250-25-000044.md) | [(0.9) d](/filings/0001364250-26-000011.md) | [39.8](/filings/0001364250-26-000032.md) | [(5.8)](/filings/0001364250-26-000041.md) | [(10.9)](/filings/0001364250-25-000044.md) | [(6.8) d](/filings/0001364250-26-000011.md) | [(2.5)](/filings/0001364250-26-000032.md) | [(2.7)](/filings/0001364250-26-000041.md) |
| Diluted EPS | $ per share | [(0.08)](/filings/0001364250-24-000048.md) | not reported | [0.05](/filings/0001364250-25-000028.md) | [0.06](/filings/0001364250-25-000036.md) | [0.03](/filings/0001364250-25-000044.md) | not reported | [0.24](/filings/0001364250-26-000032.md) | [(0.04)](/filings/0001364250-26-000041.md) | [(0.07)](/filings/0001364250-25-000044.md) | not reported | [(0.02)](/filings/0001364250-26-000032.md) | [(0.02)](/filings/0001364250-26-000041.md) |
| Basic EPS | $ per share | [(0.08)](/filings/0001364250-24-000048.md) | not reported | [0.05](/filings/0001364250-25-000028.md) | [0.06](/filings/0001364250-25-000036.md) | [0.03](/filings/0001364250-25-000044.md) | not reported | [0.24](/filings/0001364250-26-000032.md) | [(0.04)](/filings/0001364250-26-000041.md) | [(0.07)](/filings/0001364250-25-000044.md) | not reported | [(0.02)](/filings/0001364250-26-000032.md) | [(0.02)](/filings/0001364250-26-000041.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Gross profit: us-gaap:GrossProfit
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [526](/filings/0001364250-24-000048.md) | [523](/filings/0001364250-26-000011.md) | [557](/filings/0001364250-25-000028.md) | [561](/filings/0001364250-25-000036.md) | [544](/filings/0001364250-25-000044.md) | [445](/filings/0001364250-26-000011.md) | [526](/filings/0001364250-26-000032.md) | [427](/filings/0001364250-26-000041.md) | [408](/filings/0001364250-25-000044.md) | [341](/filings/0001364250-26-000041.md) | [357](/filings/0001364250-26-000032.md) | [355](/filings/0001364250-26-000041.md) |
| Total assets | $m | [9,846](/filings/0001364250-23-000070.md) | [9,644](/filings/0001364250-25-000014.md) | [9,637](/filings/0001364250-24-000028.md) | [9,564](/filings/0001364250-24-000040.md) | [9,452](/filings/0001364250-24-000048.md) | [9,404](/filings/0001364250-26-000011.md) | [9,578](/filings/0001364250-25-000028.md) | [9,434](/filings/0001364250-25-000036.md) | [9,385](/filings/0001364250-25-000044.md) | [9,288](/filings/0001364250-26-000041.md) | [9,304](/filings/0001364250-26-000032.md) | [9,551](/filings/0001364250-26-000041.md) |
| Total liabilities | $m | [5,839](/filings/0001364250-23-000070.md) | [5,799](/filings/0001364250-25-000014.md) | [5,820](/filings/0001364250-24-000028.md) | [5,801](/filings/0001364250-24-000040.md) | [5,794](/filings/0001364250-24-000048.md) | [5,745](/filings/0001364250-26-000011.md) | [5,924](/filings/0001364250-25-000028.md) | [5,842](/filings/0001364250-25-000036.md) | [5,862](/filings/0001364250-25-000044.md) | [5,813](/filings/0001364250-26-000041.md) | [5,873](/filings/0001364250-26-000032.md) | [6,036](/filings/0001364250-26-000041.md) |
| Long-term debt | $m | [5,542](/filings/0001364250-23-000070.md) | [5,543](/filings/0001364250-25-000014.md) | [5,545](/filings/0001364250-24-000028.md) | [5,546](/filings/0001364250-24-000040.md) | [5,513](/filings/0001364250-24-000048.md) | [5,498](/filings/0001364250-26-000011.md) | [5,635](/filings/0001364250-25-000028.md) | [5,563](/filings/0001364250-25-000036.md) | [5,561](/filings/0001364250-25-000044.md) | [5,549](/filings/0001364250-26-000041.md) | [5,567](/filings/0001364250-26-000032.md) | [5,723](/filings/0001364250-26-000041.md) |
| Shareholders' equity | $m | [2,337](/filings/0001364250-23-000070.md) | [2,220](/filings/0001364250-25-000014.md) | [2,203](/filings/0001364250-24-000028.md) | [2,164](/filings/0001364250-24-000040.md) | [2,090](/filings/0001364250-24-000048.md) | [2,059](/filings/0001364250-26-000011.md) | [2,046](/filings/0001364250-25-000028.md) | [1,999](/filings/0001364250-25-000036.md) | [1,948](/filings/0001364250-25-000044.md) | [1,905](/filings/0001364250-26-000041.md) | [1,871](/filings/0001364250-26-000032.md) | [1,839](/filings/0001364250-26-000041.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [90.5 d](/filings/0001364250-24-000048.md) | [94.8 d](/filings/0001364250-26-000011.md) | [139](/filings/0001364250-25-000028.md) | [91.9 d](/filings/0001364250-25-000036.md) | [104 d](/filings/0001364250-25-000044.md) | [74.1 d](/filings/0001364250-26-000011.md) | [133](/filings/0001364250-26-000032.md) | [81.3 d](/filings/0001364250-26-000041.md) | [110 d](/filings/0001364250-25-000044.md) | [63.2 d](/filings/0001364250-26-000011.md) | [117](/filings/0001364250-26-000032.md) | [96.1 d](/filings/0001364250-26-000041.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [31.7 d](/filings/0001364250-24-000048.md) | [31.7 d](/filings/0001364250-26-000011.md) | [31.8](/filings/0001364250-25-000028.md) | [31.8 d](/filings/0001364250-25-000036.md) | [31.8 d](/filings/0001364250-25-000044.md) | [31.8 d](/filings/0001364250-26-000011.md) | [31.8](/filings/0001364250-26-000032.md) | [31.8 d](/filings/0001364250-26-000041.md) | [31.8 d](/filings/0001364250-25-000044.md) | [31.8 d](/filings/0001364250-26-000011.md) | [31.8](/filings/0001364250-26-000032.md) | [31.8 d](/filings/0001364250-26-000041.md) |
| Share repurchases | $m | [0.0 d](/filings/0001364250-24-000048.md) | [0.0 d](/filings/0001364250-26-000011.md) | [0.0](/filings/0001364250-24-000028.md) | [0.0 d](/filings/0001364250-24-000040.md) | [0.0 d](/filings/0001364250-24-000048.md) | [0.0 d](/filings/0001364250-26-000011.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [176](/filings/0001364250-23-000070.md) | [176](/filings/0001364250-24-000028.md) | [169](/filings/0001364250-24-000040.md) | [167](/filings/0001364250-24-000048.md) | [167](/filings/0001364250-25-000028.md) | [167](/filings/0001364250-25-000036.md) | [167](/filings/0001364250-25-000044.md) | [167](/filings/0001364250-26-000032.md) | [167](/filings/0001364250-26-000041.md) | [167](/filings/0001364250-25-000044.md) | [167](/filings/0001364250-26-000032.md) | [167](/filings/0001364250-26-000041.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 167,485,267 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001364250-26-000041.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.